Skip to content Skip to sidebar Skip to footer

Ultimate Body–Tox recalls Ultimate Body Tox PRO capsules due to undeclared sibutramine

High Point, NC, 2016-Dec-02 — /EPR Retail News/ — Ultimate Body–Tox is voluntarily recalling all lots of Ultimate Body Tox PRO capsules to the consumer level. FDA analyses of this product found it to contain undeclared sibutramine. Sibutramine is a controlled substance that was removed from the U.S. market in October 2010 for safety reasons. The presence of sibutramine in Ultimate Body Tox PRO renders it an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall. No illnesses or injuries have been reported to Ultimate Body–Tox to date in connection with this product. This recall does not affect the sales and distribution of Ultimate Body–Tox’s other products.

The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, irregular heartbeat, or stroke.

Ultimate Body Tox PRO is marketed as a dietary supplement for weight loss and is packaged in 45 count bottles.  All lots are included in this recall. The products listed above were sold and distributed nationwide via the internet and in NC.

Ultimate Body–Tox has taken this voluntary action because it is committed to providing accurate information about its products and because of the concern for the health and safety of consumers. Ultimate Body–Tox is working with the FDA in the recall process. It sincerely regrets any inconvenience to customers. Ultimate Body–Tox is notifying its distributors and customers by phone and is arranging for return of all recalled products. Consumers, distributors, and retailers that have Ultimate Body Tox PRO should stop using and/or distributing the product, and return to place of purchase.

Consumers with questions may contact the company at 910-633-3596 Monday through Friday from 9:00am to 4:00pm EST for instructions on the return process. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Any adverse reactions experienced with the use of this product should also be reported to the FDA’s Med Watch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Consumers Contact:

Bronco Owens

Source: FDA

EPR Retail News